HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hsiu-Ting Tsai Selected Research

A-factor (Streptomyces)

1/2017Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks.
10/2016Association of the Genetic Polymorphisms RRM1 -756T>C and -269C>A With Cervical Neoplasia.
1/2016Impact of Maspin Polymorphism rs2289520 G/C and Its Interaction with Gene to Gene, Alcohol Consumption Increase Susceptibility to Oral Cancer Occurrence.
1/2013Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression.
10/2012G801A polymorphism of human stromal cell-derived factor 1 gene raises no susceptibility to neoplastic lesions of uterine cervix.
8/2010Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer.
10/2009Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hsiu-Ting Tsai Research Topics

Disease

15Neoplasms (Cancer)
01/2019 - 03/2008
14Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
01/2015 - 01/2008
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 03/2008
5Mouth Neoplasms (Oral Cancer)
01/2017 - 10/2009
5Hepatocellular Carcinoma (Hepatoma)
09/2014 - 01/2009
4Carcinogenesis
01/2014 - 08/2010
4Lymphatic Metastasis
01/2013 - 03/2008
3Infections
12/2018 - 11/2005
3Uterine Cervical Dysplasia
04/2007 - 01/2004
2Disease Progression
04/2014 - 01/2013
2Breast Neoplasms (Breast Cancer)
10/2010 - 09/2010
1Chromosome Aberrations (Chromosome Abnormalities)
05/2021
1Uniparental Disomy
05/2021
1Down Syndrome (Down's Syndrome)
05/2021
1Arthritis (Polyarthritis)
01/2021
1Gout
01/2021
1Hemorrhage
09/2020
1Confusion (Bewilderment)
11/2013
1Pneumonia (Pneumonitis)
11/2013
1Uremia
11/2013
1Abscess
11/2013
1Body Weight (Weight, Body)
10/2011
1Neoplasm Metastasis (Metastasis)
01/2009
1Hyperventilation
01/2009

Drug/Important Bio-Agent (IBA)

7A-factor (Streptomyces)IBA
01/2017 - 10/2009
5Biomarkers (Surrogate Marker)IBA
06/2014 - 01/2009
3CytokinesIBA
10/2011 - 01/2008
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2011 - 03/2008
3Glutathione Transferase (Glutathione S-Transferase)IBA
09/2010 - 03/2010
3Proteins (Proteins, Gene)FDA Link
03/2010 - 03/2008
2Tobacco Smoke Pollution (Passive Smoking)IBA
01/2021 - 04/2007
2Hemoglobins (Hemoglobin)IBA
12/2018 - 01/2009
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2017 - 01/2016
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2016 - 07/2014
2OsteopontinIBA
06/2014 - 11/2010
2Lipocalin-2IBA
06/2014 - 06/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2014 - 11/2005
2Plasminogen Activators (Plasminogen Activator)IBA
01/2013 - 08/2012
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2013 - 08/2012
2Urokinase Plasminogen Activator ReceptorsIBA
01/2013 - 08/2012
2Interleukin-2 (IL2)IBA
10/2011 - 01/2008
2Interleukin-4 (Interleukin 4)IBA
10/2011 - 01/2008
2Interleukin-10 (Interleukin 10)IBA
10/2011 - 01/2008
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2011 - 11/2009
2TransferasesIBA
09/2010 - 08/2010
2Glutathione (Reduced Glutathione)IBA
09/2010 - 08/2010
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2010 - 06/2010
2CarcinogensIBA
08/2010 - 01/2004
2CXCR4 Receptors (CXCR4 Receptor)IBA
10/2009 - 01/2009
2Messenger RNA (mRNA)IBA
11/2008 - 03/2008
2SmokeIBA
04/2007 - 01/2004
1dimemorfan (AT 17)IBA
05/2021
1Genetic Markers (Genetic Marker)IBA
05/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2019
1Ethanol (Ethyl Alcohol)IBA
01/2019
1Stem Cell FactorIBA
12/2018
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2018
1SERPIN-B5 (maspin)IBA
01/2016
1CD40 Ligand (CD40L)IBA
01/2015
1Tissue Inhibitor of Metalloproteinase-3IBA
09/2014
1fibrin fragment D (D-dimer)IBA
04/2014
1Cisplatin (Platino)FDA LinkGeneric
01/2014
1ribonucleotide reductase M2IBA
01/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2013
1growth arrest-specific protein 6IBA
11/2013
1Cadherins (E-Cadherin)IBA
02/2013
1Interleukin-18 (Interleukin 18)IBA
01/2013
1Plasminogen Activator Inhibitor 1IBA
08/2012
1cinnamaldehyde (cinnamic aldehyde)FDA Link
10/2011
1Volatile Oils (Essential Oils)IBA
10/2011
1Tissue Inhibitor of Metalloproteinase-2IBA
08/2011
1XenobioticsIBA
09/2010
1Chemokine ReceptorsIBA
09/2010
1Peroxidase (Myeloperoxidase)IBA
03/2010
1Matrix Metalloproteinases (MMPs)IBA
11/2009
1ImmunosorbentsIBA
06/2009
1EnzymesIBA
06/2009
1Chemokine CXCL12IBA
06/2009
1Cystatin CIBA
02/2009
1Cathepsin BIBA
02/2009
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2009
1hemoglobin P (Hb P)IBA
01/2009
1AntibodiesIBA
01/2008
1Interleukin-13IBA
01/2008
1Interferon-gamma (Interferon, gamma)IBA
01/2008
1Immunoglobulins (Immunoglobulin)IBA
01/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2008
1Interleukin-5 (Interleukin 5)IBA
01/2008
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2004
1AminesIBA
01/2004

Therapy/Procedure

3Therapeutics
01/2013 - 06/2010
2Length of Stay
11/2013 - 11/2013
1Punctures
09/2020
1Acupuncture Points (Acupuncture Point)
12/2018
1Acupressure (Shiatsu)
12/2018
1Drug Therapy (Chemotherapy)
12/2018
1Aftercare (After-Treatment)
06/2009